AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8529508 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy to achieve a haemoglobin A1c level of 7.1%
Number of subjects: 4209
Study 8529508 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved glucose control
Number of subjects: 4209
Study 8529508 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific therapies (sulphonylurea, metformin, insulin)
Number of subjects: 4209
Study 8529508 — intervention group
Group type: COMPARATOR
Intervention: Standard control group
Number of subjects: 4209
Study 2188871 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral S-adenosylmethionine (1600 mg/day)
Number of subjects: 220
Study 2188871 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study 340330 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (0.8 to 2.0 g per day)
Number of subjects: 348
Study 340330 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 348
Study 340330 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 348
Study 30666969 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic therapy for 8 weeks
Number of subjects: 40
Study 30666969 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 40
Study 30666969 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between synbiotic and control groups
Number of subjects: 40
Study 28058763 — intervention group
Group type: EXPERIMENTAL
Intervention: Alogliptin
Number of subjects: 5380
Study 28058763 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious hypoglycaemia (combined treatment groups)
Number of subjects: 5380
Study 28058763 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoglycaemia
Number of subjects: 5380
Study 28058763 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline HbA1c levels
Number of subjects: 5380
Study 25668008 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-message reminder 48 hours before appointment
Number of subjects: 2240
Study 25668008 — intervention group
Group type: COMPARATOR
Intervention: Normal invitation only
Number of subjects: 2240
Study 25668008 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-message reminder for those with mobile numbers recorded
Number of subjects: 2240
Study 25668008 — intervention group
Group type: COMPARATOR
Intervention: Normal invitation for those with mobile numbers recorded
Number of subjects: 2240
Study 23391635 — intervention group
Group type: EXPERIMENTAL
Intervention: S‐Monovette® serum tube collected with manual aspiration (SD‐A)
Number of subjects: 52
Study 23391635 — intervention group
Group type: COMPARATOR
Intervention: Standard vacuum tube (BD‐V)
Number of subjects: 52
Study 23391635 — intervention group
Group type: COMPARATOR
Intervention: S‐Monovette® serum tube collected by vacuum (SD‐V)
Number of subjects: 52
Study 21507689 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial saliva
Number of subjects: 54
Study 21507689 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% citric acid
Number of subjects: 54
Study 21507689 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (control)
Number of subjects: 54
Study 19623191 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-year school-based intervention targeting nutrition and physical activity behaviors
Number of subjects: 21
Study 19623191 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured observations of physical education classes, total school food environments, classroom-based educational modules, and communications and promotional campaigns
Number of subjects: 21
Study 19623191 — intervention group
Group type: EXPERIMENTAL
Intervention: Interviews and focus groups
Number of subjects: 21
Study 19623191 — intervention group
Group type: EXPERIMENTAL
Intervention: Process evaluation methods and procedures
Number of subjects: 21
Study 16454016 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemical tooth whitening system
Number of subjects: 0
Study 16454016 — intervention group
Group type: COMPARATOR
Intervention: Light-activated tooth whitening system
Number of subjects: 0
Study 15293484 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined training (CT, N=39)
Number of subjects: 77
Study 15293484 — intervention group
Group type: COMPARATOR
Intervention: Home training (HT, N=38)
Number of subjects: 77
Study 10855905 — intervention group
Group type: EXPERIMENTAL
Intervention: Categorical scale for muscle tone assessment (spastic/normal/flaccid)
Number of subjects: 39
Study 10855905 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual analogue scale (score 0 to 100) for muscle tone assessment
Number of subjects: 39
Study 9034227 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium
Number of subjects: 241
Study 8050027 — intervention group
Group type: EXPERIMENTAL
Intervention: Water jet guided Nd:YAG laser
Number of subjects: 89
Study 8050027 — intervention group
Group type: COMPARATOR
Intervention: Non-contact Nd:YAG laser
Number of subjects: 89
Study 3524607 — intervention group
Group type: EXPERIMENTAL
Intervention: Polycarbonate membranes
Number of subjects: 0
Study 3524607 — intervention group
Group type: COMPARATOR
Intervention: Cuprophane membranes
Number of subjects: 0
Study 31262193 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio tape (KT)
Number of subjects: 9
Study 31262193 — intervention group
Group type: COMPARATOR
Intervention: No taping (NT)
Number of subjects: 9
Study 29444968 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation (PMR) with diaphragmatic breathing
Number of subjects: 66
Study 29444968 — intervention group
Group type: COMPARATOR
Intervention: Control focused‐attention activity with extremity movements
Number of subjects: 66
Study 27590170 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention involving home visits, standardized advice, a booklet, daily telephone calls for reinforcement, and a reinforcement visit on day 3.
Number of subjects: 552
Study 27590170 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention (as described above)
Number of subjects: 552
Study 25048810 — intervention group
Group type: EXPERIMENTAL
Intervention: Health guidance by occupational health staff with visceral fat measurements and a weight loss support web system
Number of subjects: 181
Study 25048810 — intervention group
Group type: EXPERIMENTAL
Intervention: Health guidance by occupational health staff with a weight loss support web system
Number of subjects: 181
Study 25048810 — intervention group
Group type: COMPARATOR
Intervention: Without health guidance (control)
Number of subjects: 181
Study 22391168 — intervention group
Group type: EXPERIMENTAL
Intervention: F regimen (fludarabine 30 mg/(m(2)·d) intravenously for 3 d, every 28 days)
Number of subjects: 40
Study 22391168 — intervention group
Group type: COMPARATOR
Intervention: FC regimen (fludarabine 25 mg/(m(2)·d) plus cyclophosphamide 250 mg/(m(2)·d) intravenously for 3 d, every 28 days)
Number of subjects: 40
Study 20418244 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide-interferon
Number of subjects: 128
Study 20418244 — intervention group
Group type: COMPARATOR
Intervention: Interferon
Number of subjects: 128
Study 18424354 — intervention group
Group type: EXPERIMENTAL
Intervention: He‐Ne laser therapy (wavelength 632.8 nm, administered locally at 3.0 J/cm2, once or twice weekly)
Number of subjects: 40
Study 18424354 — intervention group
Group type: EXPERIMENTAL
Intervention: He‐Ne laser therapy
Number of subjects: 40
Study 15972594 — intervention group
Group type: EXPERIMENTAL
Intervention: Active occlusal interference
Number of subjects: 11
Study 15972594 — intervention group
Group type: COMPARATOR
Intervention: Dummy interference
Number of subjects: 11
Study 12794182 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate ingestion (CHO trial)
Number of subjects: 8
Study 12794182 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 8
Study 10570726 — intervention group
Group type: COMPARATOR
Intervention: Migraine patients
Number of subjects: 81
Study 10570726 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic tension-type headache patients
Number of subjects: 81
Study 10570726 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 81
Study 8975448 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous cold pressure therapy
Number of subjects: 24
Study 1898630 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin, 750 mg, orally twice daily for 14 days
Number of subjects: 28
Study 1898630 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 1898630 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (nonparticipants)
Number of subjects: 28
Study 1898630 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (overall)
Number of subjects: 28
Study 6307500 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-hour IV infusion of highly purified human lymphoblastoid interferon (HLBI)
Number of subjects: 40
Study 6307500 — intervention group
Group type: COMPARATOR
Intervention: IM injection of highly purified human lymphoblastoid interferon (HLBI)
Number of subjects: 40
Study 31672261 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo care applied once a day for three weeks
Number of subjects: 0
Study 31672261 — intervention group
Group type: COMPARATOR
Intervention: Standard care (15-20 min visit once a day for five days a week for three weeks)
Number of subjects: 0
Study 31672261 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo care
Number of subjects: 0
Study 31672261 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study 30648303 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical behaviour therapy (DBT) for 12 months with usual REMS treatments (n=10)
Number of subjects: 21
Study 30648303 — intervention group
Group type: COMPARATOR
Intervention: Usual REMS treatments alone (n=11)
Number of subjects: 21
Study 28763358 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol (IV bolus dose of 1 mg/kg followed by infusion of 10 μg·kg·minute over 15 minutes)
Number of subjects: 14
Study 28763358 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil (target-controlled infusion of 4 ng/mL over 15 minutes)
Number of subjects: 14
Study 25349059 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment with mechanical support and targeted intra-arterial infusion of PBSCs
Number of subjects: 55
Study 25349059 — intervention group
Group type: COMPARATOR
Intervention: Mechanical support treatment (control group)
Number of subjects: 55
Study 23281692 — intervention group
Group type: EXPERIMENTAL
Intervention: PUVA
Number of subjects: 24
Study 23281692 — intervention group
Group type: EXPERIMENTAL
Intervention: NB-UVB
Number of subjects: 24
Study 23281692 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study 21073981 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized rapeseed oil and margarine
Number of subjects: 59
Study 21073981 — intervention group
Group type: COMPARATOR
Intervention: Standard rapeseed oil and margarine
Number of subjects: 59
Study 19137426 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 year endocrine treatment alone
Number of subjects: 0
Study 19137426 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemo-endocrine therapy
Number of subjects: 0
Study 19137426 — intervention group
Group type: COMPARATOR
Intervention: Endocrine alone or no treatment
Number of subjects: 0
Study 15832952 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) 2000 microg/day
Number of subjects: 15
Study 15832952 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (BUD) 2000 microg/day
Number of subjects: 15
Study 15321057 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 Gy dose delivered at 1 mm beyond mean reference lumen
Number of subjects: 47
Study 15321057 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 Gy dose delivered at 1 mm beyond mean reference external elastic membrane
Number of subjects: 47
Study 10584776 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light therapy at 10,000 lux for 30 minutes daily for 10 to 14 days
Number of subjects: 83
Study 10584776 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning light treatment
Number of subjects: 83
Study 10584776 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening light treatment
Number of subjects: 83
Study 8683171 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-coated cardiopulmonary bypass circuits (Duraflow-II) with 200 IU/kg heparin
Number of subjects: 59
Study 8683171 — intervention group
Group type: COMPARATOR
Intervention: Non-coated cardiopulmonary bypass circuits with 350 IU/kg heparin
Number of subjects: 59
Study 1649288 — intervention group
Group type: EXPERIMENTAL
Intervention: TPN solution with Ca:P ratio of 2:1 (76 mg/kg/day Ca and 38 mg/kg/day P)
Number of subjects: 41
Study 1649288 — intervention group
Group type: EXPERIMENTAL
Intervention: TPN solution with Ca:P ratio of 1.3:1 (58 mg/kg/day Ca and 45 mg/kg/day P)
Number of subjects: 41
Study 1649288 — intervention group
Group type: EXPERIMENTAL
Intervention: TPN solution with Ca:P ratio of 1.7:1
Number of subjects: 41
Study 1649288 — intervention group
Group type: COMPARATOR
Intervention: TPN solutions with all ratios (2:1, 1.3:1, and 1.7:1)
Number of subjects: 41
Study 6876443 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole brain irradiation using 4 MV X-ray
Number of subjects: 40
Study 30812035 — intervention group
Group type: EXPERIMENTAL
Intervention: Spaced learning concept
Number of subjects: 20
Study 30812035 — intervention group
Group type: COMPARATOR
Intervention: Traditional methods
Number of subjects: 20
Study 31356229 — intervention group
Group type: EXPERIMENTAL
Intervention: Eluxadoline 100 mg twice daily for 12 weeks
Number of subjects: 346
Study 27976833 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide 1.5 mg
Number of subjects: 30
Study 27976833 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 27059971 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D robotic surgery
Number of subjects: 20
Study 27059971 — intervention group
Group type: COMPARATOR
Intervention: 3D straight-stick laparoscopy
Number of subjects: 20
Study 24552317 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 637
Study 24552317 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 637
Study 22934497 — intervention group
Group type: EXPERIMENTAL
Intervention: Reversal high-speed air turbine extraction with appropriate nursing interventions
Number of subjects: 60
Study 22934497 — intervention group
Group type: COMPARATOR
Intervention: Traditional chisel splint method
Number of subjects: 60
Study 19210948 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (mean daily dosage 10.6 mg/day)
Number of subjects: 454
Study 19210948 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 454
Study 19210948 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 454
Study 17554255 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrineal (AA source) plus Physioneal (glucose) dialysate
Number of subjects: 20
Study 17554255 — intervention group
Group type: COMPARATOR
Intervention: Physioneal alone dialysate
Number of subjects: 20
Study 17554255 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral protein intake
Number of subjects: 20
Study 15812097 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient services for general medical problems
Number of subjects: 669
Study 15812097 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency department visits
Number of subjects: 669
Study 15812097 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental and vision services
Number of subjects: 669
Study 15812097 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening tests for women (mammograms and pap tests)
Number of subjects: 669
Study 12230333 — intervention group
Group type: EXPERIMENTAL
Intervention: Postcontraction condition (3-s isometric contraction of knee extensor muscles prior to auditory stimulus)
Number of subjects: 12
Study 12230333 — intervention group
Group type: COMPARATOR
Intervention: Control condition (learned rapid knee-extension contraction response to auditory stimulus)
Number of subjects: 12
Study 12230333 — intervention group
Group type: EXPERIMENTAL
Intervention: Postcontraction condition
Number of subjects: 12
Study 12230333 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 12
Study 9475531 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified ultrafiltration
Number of subjects: 21
Study 9475531 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 21
Study 7889238 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (various dosages)
Number of subjects: 36
Study 7889238 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (25 mg/day increase)
Number of subjects: 36
Study 7889238 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower doses of aspirin
Number of subjects: 36
Study 2225560 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (6 months), dipyridamole and warfarin (2 years)
Number of subjects: 52
Study 30767 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam (3 mg/day)
Number of subjects: 62
Study 30767 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 30999897 — intervention group
Group type: EXPERIMENTAL
Intervention: TeaCrine®
Number of subjects: 24
Study 30999897 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 24
Study 30999897 — intervention group
Group type: EXPERIMENTAL
Intervention: TeaCrine® + caffeine
Number of subjects: 24
Study 30999897 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 28603054 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-minute EPBD
Number of subjects: 170
Study 28603054 — intervention group
Group type: COMPARATOR
Intervention: 5-minute EPBD
Number of subjects: 170
Study 25762758 — intervention group
Group type: EXPERIMENTAL
Intervention: Menthol tobacco-flavored e-cigarette
Number of subjects: 20
Study 25762758 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-menthol tobacco-flavored e-cigarette
Number of subjects: 20
Study 25762758 — intervention group
Group type: EXPERIMENTAL
Intervention: Preferred flavor by sex interaction
Number of subjects: 20
Study 24114461 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/day
Number of subjects: 66
Study 24114461 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg/day
Number of subjects: 66
Study 24114461 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg single dose
Number of subjects: 66
Study 24114461 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg single dose
Number of subjects: 66
Study 21696615 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually integrated TCM approach (oral counter osteophytes capsule, variable use of Tuina, acupuncture, and herbal patch) for 4 weeks
Number of subjects: 500
Study 21696615 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of a Chinese herbal drug (counter osteophytes capsule) for 4 weeks
Number of subjects: 500
Study 21696615 — intervention group
Group type: COMPARATOR
Intervention: Topical use of a Chinese herbal patch (Fufnag Zijin patch) for 4 weeks
Number of subjects: 500
Study 21696615 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture for 4 weeks
Number of subjects: 500
Study 21696615 — intervention group
Group type: COMPARATOR
Intervention: Tuina for 4 weeks
Number of subjects: 500
Study 19426239 — intervention group
Group type: EXPERIMENTAL
Intervention: S-LMA
Number of subjects: 60
Study 19426239 — intervention group
Group type: COMPARATOR
Intervention: P-LMA
Number of subjects: 60
Study 16961716 — intervention group
Group type: EXPERIMENTAL
Intervention: Levocetirizine (LCZ)
Number of subjects: 50
Study 16961716 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 11880823 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% 1-RM
Number of subjects: 20
Study 11880823 — intervention group
Group type: EXPERIMENTAL
Intervention: 60% 1-RM
Number of subjects: 20
Study 11880823 — intervention group
Group type: EXPERIMENTAL
Intervention: 90% 1-RM
Number of subjects: 20
Study 11880823 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood lactate concentration
Number of subjects: 20
Study 11880823 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG activity
Number of subjects: 20
Study 10456699 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascular Clipping System (VCS)
Number of subjects: 96
Study 10456699 — intervention group
Group type: COMPARATOR
Intervention: Polytetrafluoroethylene (PTFE) suturing
Number of subjects: 96
Study 7598053 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily iron supplementation (50 mg radiolabeled ferrous sulfate)
Number of subjects: 23
Study 7598053 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly iron supplementation (50 mg radiolabeled ferrous sulfate)
Number of subjects: 23
Study 7598053 — intervention group
Group type: COMPARATOR
Intervention: Daily iron supplementation
Number of subjects: 23
Study 2219842 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutron beam therapy
Number of subjects: 52
Study 2219842 — intervention group
Group type: COMPARATOR
Intervention: Combined treatment (radiation + surgery)
Number of subjects: 52
Study 352706 — intervention group
Group type: EXPERIMENTAL
Intervention: Molsidomine (2 mg)
Number of subjects: 6
Study 352706 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (5 mg)
Number of subjects: 6
Study 352706 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 30024323 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 h in bed overnight with a 1‐h daytime nap (8 h + 1 h)
Number of subjects: 12
Study 30024323 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 h in bed overnight with a 2‐h daytime nap (7 h + 2 h)
Number of subjects: 12
Study 30024323 — intervention group
Group type: COMPARATOR
Intervention: 9 h in bed overnight with no daytime nap (9 h + 0 h)
Number of subjects: 12
Study 25754188 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkalinized lidocaine solution (10 ml 8.4% sodium bicarbonate + 20 ml 2% lidocaine solution + 22 ml sterile Aquagel®)
Number of subjects: 54
Study 25754188 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine gel (22 ml standard 2% lidocaine gel Instillagel® + 30 ml 0.9% normal saline solution)
Number of subjects: 54
Study 25754188 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkalinized lidocaine solution
Number of subjects: 54
Study 25754188 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine gel
Number of subjects: 54